<?php
/**
 * Forum topic creation stub — Bofanglutide
 * Generated: 2026-11-04
 * To apply: execute via WP-CLI or SSH once forum access is available
 *   wp eval-file forum_pending/20261104_bofanglutide.php
 */

// Asgaros Forum REST endpoint (try first)
// POST /wp-json/asgaros-forum/v1/topics
// If unavailable, fall back to creating a standard WP post in the forum CPT

$topic_data = [
    'title'   => 'New Research Thread: Bofanglutide (GZR18) — Once-Monthly GLP-1 RA Phase 3 GRADUAL-3 Positive (Nov 4, 2026)',
    'content' => '<p><strong>Compound:</strong> Bofanglutide (GZR18)<br>'
               . '<strong>Class:</strong> GLP-1 receptor agonist<br>'
               . '<strong>Developer:</strong> Gan &amp; Lee Pharmaceuticals<br>'
               . '<strong>Dosing:</strong> Once every 4 weeks (once monthly) for maintenance; biweekly for induction</p>'
               . '<p><strong>Latest news (November 4, 2026):</strong> Phase 3 GRADUAL-3 met its primary endpoint — once-monthly dosing successfully maintained weight loss achieved over 52 weeks of biweekly dosing. This is reportedly the first global Phase IIIb RCT demonstrating a monthly maintenance strategy for a GLP-1 drug.</p>'
               . '<p><strong>Key efficacy (GRADUAL-1, Phase 3):</strong><br>'
               . '• 24 mg biweekly → −15.12% body weight (vs −1.11% placebo, 52 weeks)<br>'
               . '• 48 mg biweekly → −18.54% body weight<br>'
               . '• US Phase 2 also met primary endpoints (June 2026)</p>'
               . '<p><strong>Discussion starters:</strong><br>'
               . '1. Does once-monthly dosing matter for real-world adherence compared to weekly injectables?<br>'
               . '2. How does bofanglutide's mono-GLP-1 profile compare to tirzepatide's dual GLP-1/GIP approach for different patient profiles?<br>'
               . '3. What are your thoughts on a Chinese pharma company entering the Western obesity drug market?</p>'
               . '<p><a href="https://minmaxmuscle.com/peptides/bofanglutide">Full research dossier on MinMaxMuscle →</a></p>'
               . '<p><em>Research compounds discussed for educational purposes only. Not approved for human use. Consult a healthcare provider.</em></p>',
    'forum'   => 'peptide-research',
    'author'  => 'minmaxmuscle_admin',
];

// Output for manual review
echo "=== Forum Topic to Create ===\n";
echo "Title: " . $topic_data['title'] . "\n";
echo "Forum: " . $topic_data['forum'] . "\n";
echo "Content length: " . strlen($topic_data['content']) . " chars\n";
echo "\nTo post via REST (replace TOKEN):\n";
echo 'curl -X POST https://blog.minmaxmuscle.com/wp-json/asgaros-forum/v1/topics \\' . "\n";
echo '  -H "Authorization: Basic <BASE64_WP_CREDENTIALS>" \\' . "\n";
echo '  -H "Content-Type: application/json" \\' . "\n";
echo "  -d '" . json_encode($topic_data, JSON_PRETTY_PRINT) . "'\n";
